299 related articles for article (PubMed ID: 35011637)
1. Three-Dimensional Genome Organization in Breast and Gynecological Cancers: How Chromatin Folding Influences Tumorigenic Transcriptional Programs.
Nuñez-Olvera SI; Puente-Rivera J; Ramos-Payán R; Pérez-Plasencia C; Salinas-Vera YM; Aguilar-Arnal L; López-Camarillo C
Cells; 2021 Dec; 11(1):. PubMed ID: 35011637
[TBL] [Abstract][Full Text] [Related]
2. Contribution of transposable elements and distal enhancers to evolution of human-specific features of interphase chromatin architecture in embryonic stem cells.
Glinsky GV
Chromosome Res; 2018 Mar; 26(1-2):61-84. PubMed ID: 29335803
[TBL] [Abstract][Full Text] [Related]
3. Super-Enhancers, Phase-Separated Condensates, and 3D Genome Organization in Cancer.
Tang SC; Vijayakumar U; Zhang Y; Fullwood MJ
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740532
[TBL] [Abstract][Full Text] [Related]
4. Enhancer variants associated with Alzheimer's disease affect gene expression via chromatin looping.
Kikuchi M; Hara N; Hasegawa M; Miyashita A; Kuwano R; Ikeuchi T; Nakaya A
BMC Med Genomics; 2019 Sep; 12(1):128. PubMed ID: 31500627
[TBL] [Abstract][Full Text] [Related]
5. CTCF maintains regulatory homeostasis of cancer pathways.
Aitken SJ; Ibarra-Soria X; Kentepozidou E; Flicek P; Feig C; Marioni JC; Odom DT
Genome Biol; 2018 Aug; 19(1):106. PubMed ID: 30086769
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNAs involved in gynecological cancer.
Zhao M; Qiu Y; Yang B; Sun L; Hei K; Du X; Li Y
Int J Gynecol Cancer; 2014 Sep; 24(7):1140-5. PubMed ID: 25078335
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional dysregulation by aberrant enhancer activation and rewiring in cancer.
Okabe A; Kaneda A
Cancer Sci; 2021 Jun; 112(6):2081-2088. PubMed ID: 33728716
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional disorganization of the cancer genome occurs coincident with long-range genetic and epigenetic alterations.
Taberlay PC; Achinger-Kawecka J; Lun AT; Buske FA; Sabir K; Gould CM; Zotenko E; Bert SA; Giles KA; Bauer DC; Smyth GK; Stirzaker C; O'Donoghue SI; Clark SJ
Genome Res; 2016 Jun; 26(6):719-31. PubMed ID: 27053337
[TBL] [Abstract][Full Text] [Related]
9. Cis-acting super-enhancer lncRNAs as biomarkers to early-stage breast cancer.
Ropri AS; DeVaux RS; Eng J; Chittur SV; Herschkowitz JI
Breast Cancer Res; 2021 Oct; 23(1):101. PubMed ID: 34717732
[TBL] [Abstract][Full Text] [Related]
10. Tandem CTCF sites function as insulators to balance spatial chromatin contacts and topological enhancer-promoter selection.
Jia Z; Li J; Ge X; Wu Y; Guo Y; Wu Q
Genome Biol; 2020 Mar; 21(1):75. PubMed ID: 32293525
[TBL] [Abstract][Full Text] [Related]
11. The role of 14-3-3 proteins in gynecological tumors.
Zhang W; Shen Q; Chen M; Wang Y; Zhou Q; Tao X; Zhu X
Front Biosci (Landmark Ed); 2015 Jun; 20(6):934-45. PubMed ID: 25961534
[TBL] [Abstract][Full Text] [Related]
12. The structural and functional roles of CTCF in the regulation of cell type-specific and human disease-associated super-enhancers.
Shin HY
Genes Genomics; 2019 Mar; 41(3):257-265. PubMed ID: 30456521
[TBL] [Abstract][Full Text] [Related]
13. Super-enhancers in transcriptional regulation and genome organization.
Wang X; Cairns MJ; Yan J
Nucleic Acids Res; 2019 Dec; 47(22):11481-11496. PubMed ID: 31724731
[TBL] [Abstract][Full Text] [Related]
14. Super-enhancers in cancer.
Thandapani P
Pharmacol Ther; 2019 Jul; 199():129-138. PubMed ID: 30885876
[TBL] [Abstract][Full Text] [Related]
15. Exploring the effects of genetic variation on gene regulation in cancer in the context of 3D genome structure.
Osman N; Shawky AE; Brylinski M
BMC Genom Data; 2022 Feb; 23(1):13. PubMed ID: 35176995
[TBL] [Abstract][Full Text] [Related]
16. Prolactin Drives a Dynamic STAT5A/HDAC6/HMGN2 Cis-Regulatory Landscape Exploitable in ER+ Breast Cancer.
Craig JM; Turner TH; Harrell JC; Clevenger CV
Endocrinology; 2021 May; 162(5):. PubMed ID: 33589921
[TBL] [Abstract][Full Text] [Related]
17. Enhancer Dysfunction in 3D Genome and Disease.
Xia JH; Wei GH
Cells; 2019 Oct; 8(10):. PubMed ID: 31635067
[TBL] [Abstract][Full Text] [Related]
18. The long-range interaction landscape of gene promoters.
Sanyal A; Lajoie BR; Jain G; Dekker J
Nature; 2012 Sep; 489(7414):109-13. PubMed ID: 22955621
[TBL] [Abstract][Full Text] [Related]
19. Multiple CTCF sites cooperate with each other to maintain a TAD for enhancer-promoter interaction in the β-globin locus.
Kang J; Kim YW; Park S; Kang Y; Kim A
FASEB J; 2021 Aug; 35(8):e21768. PubMed ID: 34245617
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional genome architectural CCCTC-binding factor makes choice in duplicated enhancers at Pcdhα locus.
Wu Y; Jia Z; Ge X; Wu Q
Sci China Life Sci; 2020 Jun; 63(6):835-844. PubMed ID: 32249388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
